Peer-reviewed veterinary case report
Effects of yeast beta-glucan on metabolism in obese dogs with insulin
By Ferreira, Chayanne Silva et al.·Published in BMC veterinary research·2022·Rio Verde University, Brazil·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Metabolic variables of obese dogs with insulin resistance supplemented with yeast beta-glucan.
- Species:
- dog
Plain-English summary
A group of obese dogs was given a special diet with yeast beta-glucan to see if it could help them lose weight and improve their health. After 90 days, the dogs that received the supplement showed lower blood sugar, cholesterol, and triglyceride levels compared to those that didn't. Additionally, a hormone that helps with feelings of fullness increased in the supplemented dogs, suggesting they felt more satisfied with their food. This study suggests that adding beta-glucan to the diet could be beneficial for managing obesity in dogs.
People also search for: dog obesity treatment · yeast beta-glucan for dogs · how to help my dog lose weight
Abstract
BACKGROUND: Obesity is one of the most common nutritional disorders in dogs and cats and is related to the development metabolic comorbidities. Weight loss is the recommended treatment, but success is difficult due to the poor satiety control. Yeast beta-glucans are known as biological modifiers because of their innumerable functions reported in studies with mice and humans, but only one study with dogs was found. This study aimed to evaluate the effects of a diet supplemented with 0.1% beta-glucan on glucose, lipid homeostasis, inflammatory cytokines and satiety parameters in obese dogs. Fourteen dogs composed three experimental groups: Obese group (OG) with seven dogs with body condition score (BCS) 8 or 9; Lean group (LG) included seven non-obese dogs with a BCS of 5; and Supplemented Obese group (SOG) was the OG dogs after 90 days of consumption of the experimental diet. RESULTS: Compared to OG, SOG had lower plasma basal glycemic values (p = 0.05) and reduced serum cholesterol and triglyceride levels. TNF-α was lower in SOG than in OG (p = 0.05), and GLP-1 was increased in SOG compared to OG and LG (p = 0.02). CONCLUSION: These results are novel and important for recognizing the possibility of using beta-glucan in obesity prevention and treatment.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/34980115/